Deferitrin is primarily used as an iron chelator in medical treatments, particularly for managing iron overload conditions. It works by binding to excess iron in the body, facilitating its excretion and preventing iron-related toxicity. This makes it valuable in treating patients with thalassemia, sickle cell anemia, or other conditions requiring frequent blood transfusions, which can lead to iron accumulation. Additionally, Deferitrin is explored for its potential in mitigating iron-induced oxidative stress, which is implicated in various neurodegenerative diseases. Its ability to selectively chelate iron without significantly affecting other essential metals enhances its therapeutic appeal.